Patents by Inventor Simon LAMBDEN

Simon LAMBDEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION
    Publication number: 20230201301
    Abstract: An inhibitor of triggering receptor expressed on myeloid cells 1 (TREM-1) for use in the treatment of coronavirus disease 2019 (COVID-19) in a subject in need thereof, in particular in a subject suffering from a severe form and/or a complication of COVID-19. Also, the use of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a marker in a method for identifying a subject suffering from COVID-19 susceptible to respond to a TREM-1 inhibitor and in a method for monitoring the effectiveness of TREM-1 inhibitor administered to a subject suffering from COVID-19.
    Type: Application
    Filed: June 7, 2021
    Publication date: June 29, 2023
    Applicant: INOTREM
    Inventors: Marc DERIVE, Margarita SALCEDO-MAGGUILLI, Jean-Jacques GARAUD, Simon LAMBDEN, Aurélie OLIVIER